The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Carpenter, G., & Cohen, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38983-5 · Cited by 1,622
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
Daub, H., Ulrich Weiss, F., Wallasch, C., & Ullrich, A. (1996) · Nature · doi:10.1038/379557a0 · Cited by 1,476
Kishimoto, T., Taga, T., & Akira, S. (1994) · Cell · doi:10.1016/0092-8674(94)90333-6 · Cited by 1,328
Rosette, C., & Karin, M. (1996) · Science · doi:10.1126/science.274.5290.1194 · Cited by 1,035
Identification of Heregulin, a Specific Activator of p185 erbB2
Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., et al. (1992) · Science · doi:10.1126/science.256.5060.1205 · Cited by 962
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., & Carraway, K. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8132 · Cited by 698
Cytokine Signaling Through Nonreceptor Protein Tyrosine Kinases
Taniguchi, T. (1995) · Science · doi:10.1126/science.7716517 · Cited by 692
Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K., & Hirano, T. (1996) · Immunity · doi:10.1016/s1074-7613(00)80501-4 · Cited by 652
A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling
Carraway, K. L., & Cantley, L. C. (1994) · Cell · doi:10.1016/0092-8674(94)90564-9 · Cited by 587
Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90456-m · Cited by 577
Activation of receptor-associated tyrosine kinase JAK2 by prolactin.
Rui, H., Kirken, R. A., & Farrar, W. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37695-0 · Cited by 342
Okamoto, M., Lee, C., & Oyasu, R. (1997) · PubMed · Cited by 304
Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone
Yamauchi, T., Ueki, K., Tobe, K., Tamemoto, H., Sekine, N., Wada, M., Honjo, M., Takahashi, M., Takahashi, T., Hirai, H., et al. (1997) · Nature · doi:10.1038/36369 · Cited by 285
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
Dougall, W. C., Qian, X., Peterson, N. C., Miller, M. J., Samanta, A., & Greene, M. I. (1994) · PubMed · Cited by 180
Myers, R. B., Srivastava, S., Oelschlager, D. K., & Grizzle, W. E. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.15.1140 · Cited by 158
Intracellular expression of single chain antibodies reverts ErbB-2 transformation.
Beerli, R. R., Wels, W. S., & Hynes, N. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51027-4 · Cited by 155
Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells.
Siegall, C. B., Schwab, G., Nordan, R. P., FitzGerald, D. J., & Pastan, I. (1990) · PubMed · Cited by 153
Hirano, T. (2015) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000420758 · Cited by 148
ErbB kinases and NDF signaling in human prostate cancer cells
Grasso, A. W., Wen, D., Miller, C. M., Rhim, J. S., Pretlow, T. G., & Kung, H.-J. (1997) · Oncogene · doi:10.1038/sj.onc.1201447 · Cited by 144
Self-citationInterleukin 6 Receptor mRNA in Prostate Carcinomas and Benign Prostate Hyperplasia
Siegsmund, M. J., Yamazaki, H., & Pastan, I. H. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)35267-9 · Cited by 95
Hutchins, D. A., & Steel, C. M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580114 · Cited by 67
Regulation of Terminal differentiation of Human B-Cells by IL-6
Chen‐Kiang, S. (1995) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79275-5_23 · Cited by 33
Cited by
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Filardo, E. J., Quinn, J. A., Frackelton, A. R., & Bland, K. I. (2002) · Molecular Endocrinology · doi:10.1210/me.16.1.70 · Cited by 904
Interleukin-6 signaling pathway in targeted therapy for cancer
Guo, Y., Xu, F., Lu, T., Duan, Z., & Zhang, Z. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.04.007 · Cited by 686
Metadata
- Authors
- Qiu, Y., Ravi, L., & Kung, H.-J.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6680
- Pages
- 83-85
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1644491781
- Cited by
- 280
- References
- 23
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.